{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:11:40Z","timestamp":1777943500810,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cell-based therapy is being explored as an alternative treatment option for critical limb ischemia (CLI), a disease associated with high amputation and mortality rates and poor quality of life. However, therapeutic potential of uncultured adipose-derived stromal vascular fraction (SVF) cells has not been evaluated as a possible treatment. In this pilot study, we investigated the efficacy of multiple injections of autologous uncultured adipose-derived SVF cells to treat patients with CLI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 15 patients, from 35 to 77\u00a0years old, with rest pain and ulceration. SVF cells were injected once or twice in the ischemic limb along the arteries. Digital subtraction angiography was performed before and after cell therapy. The clinical follow up was carried out for the subsequent 12\u00a0months after the beginning of the treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Multiple intramuscular SVF cell injections caused no complications during the follow-up period. Clinical improvement occurred in 86.7% of patients. Two patients required major amputation, and the amputation sites healed completely. The rest of patients achieved a complete ulcer healing, pain relief, improved ankle-brachial pressure index and claudication walking distance, and had ameliorated their quality of life. Digital subtraction angiography performed before and after SVF cell therapy showed formation of numerous vascular collateral networks across affected arteries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Results of this pilot study demonstrate that the multiple intramuscular SVF cell injections stimulate regeneration of injured tissue and are effective alternative to achieve therapeutic angiogenesis in CLI patients who are not eligible for conventional treatment.<\/jats:p>\n                <jats:p>Trial registration number at ISRCTN registry, ISRCTN13001382. Retrospectively registered at 26\/04\/2017.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-017-1243-3","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T14:41:28Z","timestamp":1497883288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["RETRACTED ARTICLE: Stromal vascular fraction cells for the treatment of critical limb ischemia: a pilot study"],"prefix":"10.1186","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn13001382","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-7535","authenticated-orcid":false,"given":"Adas","family":"Darinskas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindaugas","family":"Paskevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gintaras","family":"Apanavicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gintaris","family":"Vilkevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liutauras","family":"Labanauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Ichim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rytis","family":"Rimdeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"1243_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCINTERVENTIONS.108.799361","volume":"2","author":"J Moriya","year":"2009","unstructured":"Moriya J, Minamino T, Tateno K, Shimizu N, Kuwabara Y, Sato Y, Saito Y, Komuro I. Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia. Circ Cardiovasc Interv. 2009;2:245\u201354.","journal-title":"Circ Cardiovasc Interv"},{"key":"1243_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3400\/avd.oa.11.00047","volume":"4","author":"T Nishida","year":"2011","unstructured":"Nishida T, Ueno Y, Kimura T, Ogawa R, Joo K, Tominaga R. Early and long-term effects of the autologous peripheral stem cell implantation for critical limb ischemia. Ann Vasc Dis. 2011;4:319\u201324.","journal-title":"Ann Vasc Dis."},{"key":"1243_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"11","author":"PK Gupta","year":"2013","unstructured":"Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, Krishnamurthy S, Anthony N, Pherwani A, Majumdar AS. A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013;11:143.","journal-title":"J Transl Med."},{"key":"1243_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12967-017-1153-4","volume":"15","author":"M Samura","year":"2017","unstructured":"Samura M, Hosoyama T, Takeuchi Y, Ueno K, Morikage N, Hamano K. Therapeutic strategies for cell-based neovascularization in critical limb ischemia. J Transl Med. 2017;15:49.","journal-title":"J Transl Med."},{"key":"1243_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0003319715595172","volume":"67","author":"A Liew","year":"2016","unstructured":"Liew A, Bhattacharya V, Shaw J, Stansby G. Cell therapy for critical limb ischemia: a meta-analysis of randomized controlled trials. Angiology. 2016;67:444\u201355.","journal-title":"Angiology"},{"key":"1243_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/scrt19","volume":"1","author":"JM Gimble","year":"2010","unstructured":"Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther. 2010;1:19.","journal-title":"Stem Cell Res Ther"},{"key":"1243_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","volume":"100","author":"JM Gimble","year":"2007","unstructured":"Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249\u201360.","journal-title":"Circ Res"},{"key":"1243_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641\u20138.","journal-title":"Cytotherapy."},{"key":"1243_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1182\/blood-2009-05-219923","volume":"115","author":"J Han","year":"2010","unstructured":"Han J, Koh YJ, Moon HR, Ryoo HG, Cho CH, Kim I, Koh GY. Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood. 2010;115:957\u201364.","journal-title":"Blood"},{"key":"1243_CR10","first-page":"1","volume":"20","author":"J Michalek","year":"2015","unstructured":"Michalek J, Moster R, Lukac L, Proefrock K, Petrasovic M, Rybar J, Capkova M, Chaloupka A, Darinskas A, Michalek J Sr, et al. Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transpl. 2015;20:1\u201336.","journal-title":"Cell Transpl."},{"key":"1243_CR11","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1253\/circj.CJ-11-1135","volume":"76","author":"HC Lee","year":"2012","unstructured":"Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, Park JH, Lee SY, Kim SP, Kim YD, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J. 2012;76:1750\u201360.","journal-title":"Circ J"},{"key":"1243_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427\u201335.","journal-title":"Lancet"},{"key":"1243_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/rej.2009.0872","volume":"12","author":"NR Dash","year":"2009","unstructured":"Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009;12:359\u201366.","journal-title":"Rejuvenation Res."},{"key":"1243_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","volume":"129","author":"A Stolzing","year":"2008","unstructured":"Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163\u201373.","journal-title":"Mech Ageing Dev"},{"key":"1243_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bjps.2012.11.008","volume":"66","author":"L Sheng","year":"2013","unstructured":"Sheng L, Yang M, Du Z, Yang Y, Li Q. Transplantation of stromal vascular fraction as an alternative for accelerating tissue expansion. J Plast Reconstr Aesthet Surg. 2013;66:551\u20137.","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"1243_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.mad.2007.06.009","volume":"128","author":"S Sugihara","year":"2007","unstructured":"Sugihara S, Yamamoto Y, Matsuura T, Narazaki G, Yamasaki A, Igawa G, Matsubara K, Miake J, Igawa O, Shigemasa C, et al. Age-related BM-MNC dysfunction hampers neovascularization. Mech Ageing Dev. 2007;128:511\u20136.","journal-title":"Mech Ageing Dev"},{"key":"1243_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ejvs.2015.08.018","volume":"50","author":"SM Peeters Weem","year":"2015","unstructured":"Peeters Weem SM, Teraa M, de Borst GJ, Verhaar MC, Moll FL. Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials. Eur J Vasc Endovasc Surg. 2015;50:775\u201383.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1243_CR18","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279\u201395.","journal-title":"Mol Biol Cell"},{"key":"1243_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1524-475X.2010.00593.x","volume":"18","author":"SK Han","year":"2010","unstructured":"Han SK, Kim HR, Kim WK. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Repair Regen. 2010;18:342\u20138.","journal-title":"Wound Repair Regen."},{"key":"1243_CR20","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.biochi.2013.06.001","volume":"95","author":"SK Kapur","year":"2013","unstructured":"Kapur SK, Katz AJ. Review of the adipose derived stem cell secretome. Biochimie. 2013;95:2222\u20138.","journal-title":"Biochimie"},{"key":"1243_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2217\/rme.11.119","volume":"7","author":"JM Gimble","year":"2012","unstructured":"Gimble JM, Bunnell BA, Guilak F. Human adipose-derived cells: an update on the transition to clinical translation. Regen Med. 2012;7:225\u201335.","journal-title":"Regen Med."},{"key":"1243_CR22","doi-asserted-by":"publisher","first-page":"931420","DOI":"10.1155\/2015\/931420","volume":"2015","author":"R Compagna","year":"2015","unstructured":"Compagna R, Amato B, Massa S, Amato M, Grande R, Butrico L, de Franciscis S, Serra R. Cell therapy in patients with critical limb ischemia. Stem Cells Int. 2015;2015:931420.","journal-title":"Stem Cells Int."},{"key":"1243_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292\u20138.","journal-title":"Circulation"},{"key":"1243_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1749-8090-6-43","volume":"6","author":"GU Premaratne","year":"2011","unstructured":"Premaratne GU, Ma LP, Fujita M, Lin X, Bollano E, Fu M. Stromal vascular fraction transplantation as an alternative therapy for ischemic heart failure: anti-inflammatory role. J Cardiothorac Surg. 2011;6:43.","journal-title":"J Cardiothorac Surg"}],"updated-by":[{"DOI":"10.1186\/s12967-020-02266-3","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"record-id":"22491"},{"DOI":"10.1186\/s12967-020-02266-3","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-017-1243-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-017-1243-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:43:55Z","timestamp":1628613835000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-017-1243-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1186\/s12967-017-1243-3","relation":{"retraction":[{"id-type":"doi","id":"10.1186\/s12967-020-02266-3","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"assertion":[{"value":"27 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Editor-in-Chief and the publisher have retracted this article [1]. An investigation by the Lithuanian Bioethics Committee concluded that, contrary to the statements in the article, the study described was not conducted in the Vilnius City Clinical Hospital and the Commission of Medical Ethics did not issue any approval for such a study.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"143"}}